NCT07024693Phase 2Recruiting

DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy

Study sponsor: Design Therapeutics, Inc. · DSGN

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-12Estimated
Enrollment · participants70Estimated
Source updated2026-09-28Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Planned enrollment increased by 42 participants

Before: 28 participants (planned). After: 70 participants (planned).

Primary completion date changed

Before: Sep 2026. After: Dec 2027.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview